Business
Australian firm receives FDA approval for ‘breakthrough’ COVID test – Sydney Morning Herald
Brisbane-based diagnostics company Ellume plans to deliver 20 million COVID-19 tests to the US within the first half of 2021.
“By authorising a test for over-the-counter use, the FDA allows it to be sold in places like drug stores, where a patient can buy it, swab their nose, run the test and find out their results in as little as 20 minutes,” Hahn said in a statement.
Lamar Alexander, the chair of the Senate health committee, said: “This is a genuine breakthrough in COVID-19 testing.”
Ellume’s CEO and founder, Sean Parsons, in the company’s east Brisbane lab.
The US is currently testing around 2 million people a day,…
-
General24 hours agoAbattoir worker in serious condition after workplace accident in Echuca
-
Noosa News15 hours agoFull house as Minister shares vision for Sunshine Coast transport
-
Business12 hours agoWhy I’d buy these top ASX 200 shares next
-
Business10 hours ago10 reasons to buy and hold this tech stock forever